Related Experiment Videos
New drugs in pediatric dermatology
1Hospital for Sick Children, Toronto, Ontario, Canada.
Current Opinion in Pediatrics
|April 1, 1993
Summary
New therapeutic agents like calcipotriol and acyclovir offer improved treatments for skin conditions. While some drugs show promise for psoriasis and viral infections, others have limitations for widespread use.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Recent advancements have introduced novel therapeutic agents for infectious and inflammatory skin diseases.
- Several key drugs are now available, necessitating a review of their efficacy and applications.
Purpose of the Study:
- To review five significant therapeutic agents for skin conditions: calcipotriol, EMLA, interferon-alpha 2a, cyclosporine, and acyclovir.
- To summarize the current understanding of their applications, benefits, and limitations in clinical practice.
Main Methods:
- Literature review of recently available therapeutic agents for skin diseases.
- Analysis of clinical data and reported outcomes for calcipotriol, EMLA, interferon-alpha 2a, cyclosporine, and acyclovir.
Main Results:
- Calcipotriol is beneficial for adult plaque psoriasis but not curative; pediatric use is under investigation.
- EMLA aids in pain prevention for minor procedures.
- Interferon-alpha 2a shows promise for vascular lesion complications.
- Cyclosporine is effective for atopic dermatitis and psoriasis but systemic use is limited by side effects; topical use has poor penetration.
- Acyclovir has significantly improved herpes simplex virus infections, especially neonatal herpes, but its role in varicella is uncertain.
Conclusions:
- The reviewed agents offer diverse therapeutic benefits for various skin conditions, ranging from psoriasis to viral infections.
- Limitations such as side effects, efficacy, and specific indications require careful consideration for optimal patient management.
- Further research is needed to fully elucidate the potential of these agents, particularly in pediatric populations and for specific conditions like varicella.